
Photo taken from ICON plc/LinkedIn
May 20, 2024, 06:16
ICON plc – How a flexible approach to clinical trials is reimagining the patient journey
ICON plc shared a post on LinkedIn:
“Read our latest article in Pharmaceutical Executive to consider how a flexible approach to clinical trials is reimagining the patient journey and rebalancing the workload for each stakeholder involved in clinical research. ”
Read further.
Source: ICON plc/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 21, 2025, 21:13
May 21, 2025, 19:10
May 21, 2025, 18:49
May 21, 2025, 18:11
May 21, 2025, 18:05
May 21, 2025, 18:02